KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Other financing activities (2017 - 2025)

Johnson & Johnson's Other financing activities history spans 12 years, with the latest figure at -$26.0 million for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to -$26.0 million; the TTM value through Dec 2025 reached -$34.0 million, up 10.53%, while the annual FY2025 figure was -$34.0 million, 10.53% up from the prior year.
  • Other financing activities for Q4 2025 was -$26.0 million at Johnson & Johnson, up from -$49.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $275.0 million in Q1 2021 and bottomed at -$384.0 million in Q4 2023.
  • The 5-year median for Other financing activities is -$8.0 million (2023), against an average of -$6.5 million.
  • The largest annual shift saw Other financing activities skyrocketed 238.96% in 2021 before it tumbled 4700.0% in 2023.
  • A 5-year view of Other financing activities shows it stood at $18.0 million in 2021, then plummeted by 866.67% to -$138.0 million in 2022, then plummeted by 178.26% to -$384.0 million in 2023, then soared by 80.47% to -$75.0 million in 2024, then soared by 65.33% to -$26.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Other financing activities are -$26.0 million (Q4 2025), -$49.0 million (Q3 2025), and $1.0 million (Q2 2025).